$NTIP
NETWORK-1 TECHNOLOGIES, INC. Stock $ntip

$ntip Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000107261322000514 Filed on August 15, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue
YoY Change
Cost Of Revenue	$0.00	$0.00
YoY Change	-100.0%
Gross Profit	$0.00	$0.00	$0.00
YoY Change	-100.0%		-100.0%
Gross Profit Margin
Selling, General & Admin	$756.0K	$758.0K	$822.0K
YoY Change	-40.89%	-8.45%	-11.33%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$82.00K	$76.00K	$75.00K
YoY Change	10.81%	4.11%	1.35%
% of Gross Profit
Operating Expenses	$838.0K	$834.0K	$897.0K
YoY Change	-38.06%	-7.44%	-10.39%
Operating Profit	-$838.0K	-$834.0K	-$897.0K
YoY Change	-109.27%	-7.44%	-107.31%
Interest Expense	$3.780M	-$445.0K	-$434.0K
YoY Change	13900.0%	-480.34%	-10950.0%
% of Operating Profit
Other Income/Expense, Net	$4.051M	-$445.0K	-$434.0K
YoY Change	14903.7%	-480.34%
Pretax Income	$3.213M	-$1.279M	-$1.331M
YoY Change	-64.55%	63.14%	-110.84%
Income Tax	$702.0K	-$102.0K	-$452.0K
% Of Pretax Income	21.85%
Net Earnings	$2.226M	-$1.532M	-$1.312M
YoY Change	-66.22%	95.66%	-113.88%
Net Earnings / Revenue
Basic Earnings Per Share	$0.09	-$0.06	-$0.05
Diluted Earnings Per Share	$0.09	-$0.06	-$54.87K
COMMON SHARES
Basic Shares Outstanding	23.77M shares	23.85M shares	23.91M shares
Diluted Shares Outstanding	24.07M shares	23.85M shares	23.91M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$48.92M	$52.13M	$56.54M
YoY Change	-19.59%	-3.07%	36.98%
Cash & Equivalents	$21.16M	$25.53M	$42.46M
Short-Term Investments	$27.76M	$26.59M	$14.08M
Other Short-Term Assets	$108.0K	$239.0K	$111.0K
YoY Change	315.38%	312.07%	26.14%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$49.37M	$52.36M	$56.65M
YoY Change	-18.89%	-2.73%	-5.67%
LONG-TERM ASSETS
Property, Plant & Equipment	$177.0K	$194.0K
YoY Change
Goodwill		$5.000M
YoY Change
Intangibles
YoY Change
Long-Term Investments	$7.661M	$1.863M	$3.218M
YoY Change	90.67%	-55.69%	-27.52%
Other Assets	$13.00K	$13.00K	$13.00K
YoY Change	0.0%	0.0%	0.0%
Total Long-Term Assets	$9.526M	$4.827M	$5.064M
YoY Change	73.99%	-15.54%	-15.1%
TOTAL ASSETS
Total Short-Term Assets	$49.37M	$52.36M	$56.65M
Total Long-Term Assets	$9.526M	$4.827M	$5.064M
Total Assets	$58.89M	$57.19M	$61.71M
YoY Change	-11.23%	-3.96%	-6.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$348.0K	$527.0K	$490.0K
YoY Change	-12.78%	32.75%	34.99%
Accrued Expenses	$460.0K	$427.0K	$569.0K
YoY Change	155.56%	-61.7%	-91.28%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$812.0K	$1.073M	$4.011M
YoY Change	-77.54%	-51.71%	-48.44%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$111.0K	$128.0K
YoY Change
Total Long-Term Liabilities	$111.0K	$128.0K	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$812.0K	$1.073M	$4.011M
Total Long-Term Liabilities	$111.0K	$128.0K	$0.00
Total Liabilities	$1.899M	$1.201M	$4.113M
YoY Change	-55.79%	-59.14%	-51.89%
SHAREHOLDERS EQUITY
Retained Earnings	-$9.996M	-$10.83M
YoY Change
Common Stock	$237.0K	$238.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$56.99M	$55.99M	$57.60M
YoY Change
Total Liabilities & Shareholders Equity	$58.89M	$57.19M	$61.71M
YoY Change	-11.23%	-3.96%	-6.52%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	$2.226M	-$1.532M	-$1.312M
YoY Change	-66.22%	95.66%	-113.88%
Depreciation, Depletion And Amortization	$82.00K	$76.00K	$75.00K
YoY Change	10.81%	4.11%	1.35%
Cash From Operating Activities	-$572.0K	-$3.859M	-$749.0K
YoY Change	-106.87%	-130.52%	-45.53%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	-$524.0K
YoY Change	-100.0%	-100.0%	6450.0%
Acquisitions
YoY Change
Other Investing Activities	-$2.435M	-$12.82M	$537.0K
YoY Change	-18.43%	-618.24%	-55.47%
Cash From Investing Activities	-$2.435M	-$12.82M	$13.00K
YoY Change	-18.94%	-630.9%	-98.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.361M	-252.0K	-1.302M
YoY Change	13.04%	92.37%	7.96%
NET CHANGE
Cash From Operating Activities	-572.0K	-3.859M	-749.0K
Cash From Investing Activities	-2.435M	-12.82M	13.00K
Cash From Financing Activities	-1.361M	-252.0K	-1.302M
Net Change In Cash	-4.368M	-16.93M	-2.038M
YoY Change	-205.94%	-213.39%	47.36%
FREE CASH FLOW
Cash From Operating Activities	-$572.0K	-$3.859M	-$749.0K
Capital Expenditures	$0.00	$0.00	-$524.0K
Free Cash Flow	-$572.0K	-$3.859M	-$225.0K
YoY Change	-106.85%	-130.38%	-83.54%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	1-15288
	dei	Entity Registrant Name EntityRegistrantName	NETWORK-1 TECHNOLOGIES, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	11-3027591
	dei	Entity Address Address Line1 EntityAddressAddressLine1	65 Locust Avenue
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Third Floor
	dei	Entity Address City Or Town EntityAddressCityOrTown	New Canaan
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CT
	dei	Entity Central Index Key EntityCentralIndexKey	0001065078
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2022Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet		usd
CY2021Q2	us-gaap	Revenues Revenues		usd
CY2021Q2	nssi	Cost Of Revenues CostOfRevenues		usd
CY2022Q2	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2022Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared
CY2021Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared
CY2022Q1	nssi	Vesting Of Restricted Stock Units VestingOfRestrictedStockUnits		usd
CY2022Q2	nssi	Vesting Of Restricted Stock Units VestingOfRestrictedStockUnits		usd
CY2021Q1	nssi	Vesting Of Restricted Stock Units VestingOfRestrictedStockUnits		usd
CY2021Q2	nssi	Vesting Of Restricted Stock Units VestingOfRestrictedStockUnits		usd
	nssi	Amortization Of Right Of Use Asset AmortizationOfRightOfUseAsset		usd
	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits		usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
	nssi	Convertible Note Investment ConvertibleNoteInvestment		usd
	nssi	Value Of Shares Delivered To Fund Withholding Taxes ValueOfSharesDeliveredToFundWithholdingTaxes		usd
	us-gaap	Interest Paid InterestPaid		usd
	us-gaap	Interest Paid InterestPaid		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	nssi	Accrued Dividend Rights On Restricted Stock Units AccruedDividendRightsOnRestrictedStockUnits		usd
	nssi	Right Of Use Asset Obtained In Exchange For Lease Liability RightOfUseAssetObtainedInExchangeForLeaseLiability		usd
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants		shares
CY2022Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants		shares
CY2021Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants		shares
	nssi	Options And Warrants Excluded From Computation Of Diluted Income Loss Per Share Because Effect Of Inclusion Would Have Been Antidilutive OptionsAndWarrantsExcludedFromComputationOfDilutedIncomeLossPerShareBecauseEffectOfInclusionWouldHaveBeenAntidilutive		shares
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent		usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability		usd
CY2021Q2	us-gaap	Operating Lease Cost OperatingLeaseCost		usd
	us-gaap	Operating Lease Cost OperatingLeaseCost		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	06840
	dei	City Area Code CityAreaCode	203
	dei	Local Phone Number LocalPhoneNumber	920-1055
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
	dei	Trading Symbol TradingSymbol	NTIP
	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	23768506	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25532000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	44497000	usd
CY2022Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	26593000	usd
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	15126000	usd
CY2022Q2	us-gaap	Other Assets Current OtherAssetsCurrent	239000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	150000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	52364000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	59773000	usd
CY2022Q2	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	1757000	usd
CY2021Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	1384000	usd
CY2022Q2	us-gaap	Equity Method Investments EquityMethodInvestments	1863000	usd
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	2651000	usd
CY2022Q2	nssi	Convertible Note Investments ConvertibleNoteInvestments	1000000	usd
CY2021Q4	nssi	Convertible Note Investments ConvertibleNoteInvestments	1000000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	194000	usd
CY2022Q2	us-gaap	Security Deposit SecurityDeposit	13000	usd
CY2021Q4	us-gaap	Security Deposit SecurityDeposit	13000	usd
CY2022Q2	us-gaap	Other Assets OtherAssets	4827000	usd
CY2021Q4	us-gaap	Other Assets OtherAssets	5048000	usd
CY2022Q2	us-gaap	Assets Assets	57191000	usd
CY2021Q4	us-gaap	Assets Assets	64821000	usd
CY2022Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	119000	usd
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	2952000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	527000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	459000	usd
CY2022Q2	nssi	Accrued Contingency Fees And Related Costs AccruedContingencyFeesAndRelatedCosts	147000	usd
CY2021Q4	nssi	Accrued Contingency Fees And Related Costs AccruedContingencyFeesAndRelatedCosts	137000	usd
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	56000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	380000	usd
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	158000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	180000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	66000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1073000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4108000	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	554000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	128000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	1201000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	4662000	usd
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23791194	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23791194	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23792212	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23792212	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	238000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	238000	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	66593000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	66361000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10825000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6428000	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-16000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-12000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	55990000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	60159000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	57191000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	64821000	usd
	us-gaap	Revenues Revenues	18692000	usd
	nssi	Cost Of Revenues CostOfRevenues	5420000	usd
CY2022Q2	us-gaap	Professional Fees ProfessionalFees	157000	usd
CY2021Q2	us-gaap	Professional Fees ProfessionalFees	308000	usd
	us-gaap	Professional Fees ProfessionalFees	407000	usd
	us-gaap	Professional Fees ProfessionalFees	663000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	423000	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	461000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	940000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	974000	usd
CY2022Q2	us-gaap	Adjustment For Amortization AdjustmentForAmortization	76000	usd
CY2021Q2	us-gaap	Adjustment For Amortization AdjustmentForAmortization	73000	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	151000	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	147000	usd
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	178000	usd
CY2021Q2	us-gaap	Share Based Compensation ShareBasedCompensation	59000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	233000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	118000	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	834000	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	901000	usd
	us-gaap	Operating Expenses OperatingExpenses	1731000	usd
	us-gaap	Operating Expenses OperatingExpenses	7322000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-834000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-901000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1731000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	11370000	usd
CY2022Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	131000	usd
CY2021Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	68000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	211000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	118000	usd
CY2022Q2	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-576000	usd
CY2021Q2	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	49000	usd
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-1090000	usd
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	8000	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-445000	usd
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	117000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-879000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	126000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-1279000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-784000	usd
	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-2610000	usd
	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	11496000	usd
CY2021Q2	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-180000	usd
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	710000	usd
CY2022Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-102000	usd
CY2021Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-52000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-554000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1672000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-102000	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-232000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-554000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2382000	usd
CY2022Q2	nssi	Loss Income Before Share Of Net Losses Of Equity Method Investee LossIncomeBeforeShareOfNetLossesOfEquityMethodInvestee	-1177000	usd
CY2021Q2	nssi	Loss Income Before Share Of Net Losses Of Equity Method Investee LossIncomeBeforeShareOfNetLossesOfEquityMethodInvestee	-552000	usd
	nssi	Loss Income Before Share Of Net Losses Of Equity Method Investee LossIncomeBeforeShareOfNetLossesOfEquityMethodInvestee	-2056000	usd
	nssi	Loss Income Before Share Of Net Losses Of Equity Method Investee LossIncomeBeforeShareOfNetLossesOfEquityMethodInvestee	9114000	usd
CY2022Q2	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	-355000	usd
CY2021Q2	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	-231000	usd
	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	-788000	usd
	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	-446000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-1532000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-783000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2844000	usd
	us-gaap	Net Income Loss NetIncomeLoss	8668000	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.36
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.35
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23854438	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23839455	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23864053	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24106169	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23854438	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23839455	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23864053	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24878257	shares
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.05
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.05
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-1532000	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-783000	usd
	us-gaap	Profit Loss ProfitLoss	-2844000	usd
	us-gaap	Profit Loss ProfitLoss	8668000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-1000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-3000	usd
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-4000	usd
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	8000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1533000	usd
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-786000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2848000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	8676000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	60159000	usd
CY2022Q1	nssi	Dividends And Dividend Equivalents Declared DividendsAndDividendEquivalentsDeclared	-1190000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	55000	usd
CY2022Q1	nssi	Value Of Shares Delivered To Pay Withholding Taxes ValueOfSharesDeliveredToPayWithholdingTaxes	-112000	usd
CY2022Q1	nssi	Net Unrealized Loss On Corporate Bonds And Notes NetUnrealizedLossOnCorporateBondsAndNotes	-3000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1312000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	57597000	usd
CY2022Q2	nssi	Dividend Equivalents Rights Paid DividendEquivalentsRightsPaid	-5000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	178000	usd
CY2022Q2	nssi	Treasury Stock Purchased And Retired TreasuryStockPurchasedAndRetired	-247000	usd
CY2022Q2	nssi	Net Unrealized Loss On Corporate Bonds And Notes NetUnrealizedLossOnCorporateBondsAndNotes	-1000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-1532000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	55990000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	49162000	usd
CY2021Q1	nssi	Dividends And Dividend Equivalents Declared DividendsAndDividendEquivalentsDeclared	-1216000	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	59000	usd
CY2021Q1	nssi	Net Unrealized Loss On Corporate Bonds And Notes NetUnrealizedLossOnCorporateBondsAndNotes	11000	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	9451000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	57467000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	59000	usd
CY2021Q2	nssi	Treasury Stock Purchased And Retired TreasuryStockPurchasedAndRetired	-131000	usd
CY2021Q2	nssi	Net Unrealized Loss On Corporate Bonds And Notes NetUnrealizedLossOnCorporateBondsAndNotes	-3000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-783000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	56609000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2844000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8668000	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	151000	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	147000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	233000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	118000	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-788000	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-446000	usd
	nssi	Unrealized Loss Gain On Marketable Securities UnrealizedLossGainOnMarketableSecurities	-808000	usd
	nssi	Unrealized Loss Gain On Marketable Securities UnrealizedLossGainOnMarketableSecurities	29000	usd
	nssi	Amortization Of Right Of Use Asset AmortizationOfRightOfUseAsset	10000	usd
	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-554000	usd
	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	1672000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	89000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-62000	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-2833000	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	710000	usd
	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	8000	usd
	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	68000	usd
	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	-200000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-10000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-336000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-332000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4608000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	11270000	usd
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-4004000	usd
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-9020000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	16283000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	4341000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	524000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	67000	usd
	nssi	Convertible Note Investment ConvertibleNoteInvestment	1000000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-12803000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	3612000	usd
	nssi	Options And Warrants Excluded From Computation Of Diluted Income Loss Per Share Because Effect Of Inclusion Would Have Been Antidilutive OptionsAndWarrantsExcludedFromComputationOfDilutedIncomeLossPerShareBecauseEffectOfInclusionWouldHaveBeenAntidilutive	1160000	shares
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1195000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1206000	usd
	nssi	Value Of Shares Delivered To Fund Withholding Taxes ValueOfSharesDeliveredToFundWithholdingTaxes	112000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	247000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	131000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1554000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1337000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-18965000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	13545000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	44497000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25505000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25532000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	39050000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3000000	usd
	nssi	Accrued Dividend Rights On Restricted Stock Units AccruedDividendRightsOnRestrictedStockUnits	10000	usd
	nssi	Right Of Use Asset Obtained In Exchange For Lease Liability RightOfUseAssetObtainedInExchangeForLeaseLiability	204000	usd
	us-gaap	Gain Contingency Patents Found Infringed Upon Number GainContingencyPatentsFoundInfringedUponNumber	96	integer
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_845_eus-gaap--UseOfEstimates_z1pNwrWDoHD2" style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 6pt; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[1]</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zIzXQUk1gTa5">Use of Estimates and Assumptions</span></b></span></td></tr></table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. The significant estimates and assumptions made in the preparation of the Company’s unaudited condensed consolidated financial statements include legal fees and related costs, income taxes, valuation of patents and equity method investments, including evaluation of the Company’s basis difference. Actual results could be materially different from those estimates, upon which the carrying values were based.</span></p>
CY2022Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022Q2	us-gaap	Cash Uninsured Amount CashUninsuredAmount	4404000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	633000	usd
CY2022Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	409000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	224000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	224000	usd
CY2022Q1	nssi	Contingent Common Stock Issued Upon Achieving Certain Milestones ContingentCommonStockIssuedUponAchievingCertainMilestones	375000	usd
CY2022Q1	nssi	First50 Million First50Million	0.15	pure
CY2022Q1	nssi	Greater Than50 Million GreaterThan50Million	0.175	pure
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8473000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	7949000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-6716000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-6565000	usd
CY2022Q2	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	1757000	usd
CY2021Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	1384000	usd
CY2022Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	76000	usd
CY2021Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	73000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	151000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	147000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	328000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	158000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	118000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	118000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	118000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	917000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1757000	usd
CY2022Q2	nssi	Obligated To Pay Seller Net Proceed Percentage ObligatedToPaySellerNetProceedPercentage	0.125	pure
CY2022Q2	nssi	First125 Million First125Million	0.10	pure
CY2022Q2	nssi	Next125 Million Next125Million	0.15	pure
CY2022Q2	nssi	Over250 Million Over250Million	0.20	pure
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	12500	shares
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	3.36
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	670000	shares
	nssi	Issuance Weightedaverage Grant Date Fair Value IssuanceWeightedaverageGrantDateFairValue	1.92
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	22500	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	2.55
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	660000	shares
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.93
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1160000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	685000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23864053	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24106169	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23854438	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23839455	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	772088	shares
	nssi	Weightedaverage Common Shares Outstanding Diluted WeightedaverageCommonSharesOutstandingDiluted	23864053	shares
	nssi	Weightedaverage Common Shares Outstanding Diluted WeightedaverageCommonSharesOutstandingDiluted	24878257	shares
CY2022Q2	nssi	Weightedaverage Common Shares Outstanding Diluted WeightedaverageCommonSharesOutstandingDiluted	23854438	shares
CY2021Q2	nssi	Weightedaverage Common Shares Outstanding Diluted WeightedaverageCommonSharesOutstandingDiluted	23839455	shares
CY2022Q2	nssi	Options And Warrants Excluded From Computation Of Diluted Income Loss Per Share Because Effect Of Inclusion Would Have Been Antidilutive OptionsAndWarrantsExcludedFromComputationOfDilutedIncomeLossPerShareBecauseEffectOfInclusionWouldHaveBeenAntidilutive	1160000	shares
CY2021Q2	nssi	Options And Warrants Excluded From Computation Of Diluted Income Loss Per Share Because Effect Of Inclusion Would Have Been Antidilutive OptionsAndWarrantsExcludedFromComputationOfDilutedIncomeLossPerShareBecauseEffectOfInclusionWouldHaveBeenAntidilutive	685000	shares
CY2022Q1	nssi	Hft Patent Acqusition Cash At Closing HftPatentAcqusitionCashAtClosing	500000	usd
CY2022Q1	nssi	Obligation To Pay Hft Seller Additional Cash Based On Achieving Certain Milestones ObligationToPayHftSellerAdditionalCashBasedOnAchievingCertainMilestones	500000	usd
	nssi	Recognition Net Proceeds Payment Related To Mirror Worlds Patents RecognitionNetProceedsPaymentRelatedToMirrorWorldsPatents	3127000	usd
CY2022Q2	nssi	First100 First100	0.14	pure
CY2022Q2	nssi	Next100 Next100	0.05	pure
CY2022Q2	nssi	Aadditional Consideration AadditionalConsideration	250000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.042	pure
CY2022Q2	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P3Y
CY2022Q2	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P2Y9M18D
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	194000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	66000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	128000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	194000	usd
CY2022Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	12000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	12000	usd
CY2022Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	12000	usd
CY2021Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	28000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	36000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	56000	usd
CY2022Q2	us-gaap	Lease Cost LeaseCost	24000	usd
CY2021Q2	us-gaap	Lease Cost LeaseCost	28000	usd
	us-gaap	Lease Cost LeaseCost	48000	usd
	us-gaap	Lease Cost LeaseCost	56000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	36000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	73000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	73000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	24000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	206000	usd
CY2022Q2	nssi	Operating Leases Imputed Interest OperatingLeasesImputedInterest	-12000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	194000	usd
CY2022Q2	us-gaap	Investments Investments	6000000	usd
CY2022Q2	us-gaap	Goodwill Goodwill	5000000	usd
CY2022Q2	us-gaap	Investments And Other Noncurrent Assets InvestmentsAndOtherNoncurrentAssets	1000000	usd
CY2021Q2	nssi	Stock Repurchase Program Dollar Amount That May Be Repurchased StockRepurchaseProgramDollarAmountThatMayBeRepurchased	5000000	usd
	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	9087214	shares
	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	17473100	usd
	nssi	Weighted Average Price Per Share Common Stock Subject To Repurchase WeightedAveragePricePerShareCommonStockSubjectToRepurchase	1.92
CY2022Q2	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	103080	shares
CY2022Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	247824	usd
CY2022Q2	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	2.40
CY2022Q2	nssi	Value Of Remaining Shares That May Be Repurchased ValueOfRemainingSharesThatMayBeRepurchased	3682905	usd
CY2022Q2	nssi	Royalty Receivables RoyaltyReceivables	0	usd
CY2021Q4	nssi	Royalty Receivables RoyaltyReceivables	0	usd
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.05

Files In Submission

Name	View Source	Status
0001072613-22-000514-index-headers.html	Edgar Link	pending
0001072613-22-000514-index.html	Edgar Link	pending
0001072613-22-000514.txt	Edgar Link	pending
0001072613-22-000514-xbrl.zip	Edgar Link	pending
exh31-1_18635.htm	Edgar Link	pending
exh31-2_18635.htm	Edgar Link	pending
exh32-1_18635.htm	Edgar Link	pending
exh32-2_18635.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
network1_10q-063022.htm	Edgar Link	pending
nssi-20220630.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
nssi-20220630_def.xml	Edgar Link	unprocessable
nssi-20220630_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
nssi-20220630_lab.xml	Edgar Link	unprocessable
network1_10q-063022_htm.xml	Edgar Link	completed
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
nssi-20220630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NTIP
NETWORK-1 TECHNOLOGIES, INC. Stock $ntip

2022 Q3 Form 10-Q Financial Statement

#000107261322000514 Filed on August 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NTIP NETWORK-1 TECHNOLOGIES, INC. Stock $ntip

2022 Q3 Form 10-Q Financial Statement

#000107261322000514 Filed on August 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NTIP
NETWORK-1 TECHNOLOGIES, INC. Stock $ntip